850325 | 10:0 PC
1,2-didecanoyl-sn-glycero-3-phosphocholine

10:0 PC
1,2-didecanoyl-sn-glycero-3-phosphocholine
The list of Phosphatidylcholine products offered by Avanti is designed to provide compounds having a variety of physical properties. Products available include short chain (C3-C8 are water soluble and hygroscopic), saturated, multi-unsaturated and mixed acid PC's. All of the products are purified by HPLC, and special precautions are taken to protect the products from oxidization and hydrolysis. Several of these products are manufactured under the current guidelines of Good Manufacturing Practice and are available for pharmaceutical use. If you have a requirement for a choline derivative not found on our list, please call us: custom synthesis is one of our specialties.
CAS Registry Number is a Registered Trademark of the American Chemical Society
PC(10:0/10:0)
- ChemDraw File
- 3D Structure
- Structure
- Safety Data Sheet
- Safety Data Sheet
- Certificate of Analysis (Lot No. 850325C-200MG-A-043 and 5635CNA043)
- Certificate of Analysis (Lot No. 850325C-25MG-A-043 and 5635CJA043)
- Certificate of Analysis (Lot No. 850325P-200MG-A-043 and 5635PNA043)
- Certificate of Analysis (Lot No. 850325P-25MG-A-043 and 5635PJA043)
- Certificate of Analysis (Lot No. 850325P-200MG-B-043 and 5635PNB043)
- Certificate of Analysis (Lot No. 850325P-25MG-B-043 and 5635PJB043)
- Certificate of Analysis (Lot No. 850325C-25MG-A-044 and 5635CJA044)
- Certificate of Analysis (Lot No. 850325P-200MG-C-043 and 5635PNC043)
- Certificate of Analysis (Lot No. 850325P-200MG-A-044 and 5635PNA044)
- Certificate of Analysis (Lot No. 850325C-25MG-B-043 and 5635CJB043)
- Certificate of Analysis (Lot No. 850325C-200MG-A-046 and 5635CNA046)
- Certificate of Analysis (Lot No. 850325P-200MG-C-043 and 5635PNC043)
- Certificate of Analysis (Lot No. 850325P-25MG-A-049 and 5635PJA049)
- Certificate of Analysis (Lot No. 850325P-200MG-A-049 and 5635PNA049)
Chao CC, Gutiérrez-Vázquez C, Rothhammer V, Mayo L, Wheeler MA, Tjon EC, Zandee SEJ, Blain M, de Lima KA, Takenaka MC, Avila-Pacheco J, Hewson P, Liu L, Sanmarco LM, Borucki DM, Lipof GZ, Trauger SA, Clish CB, Antel JP, Prat A, Quintana FJ. Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS. Cell. 2019 Dec 12;179(7):1483-1498.e22. doi: 10.1016/j.cell.2019.11.016. Epub 2019 Dec 5.
PubMed ID: 31813625Stottrup BL, TigreLazo J, Bagonza VB, Kunz JC, Zasadzinski JA. Comparison of Line Tension Measurement Methods for Lipid Monolayers at Liquid-Liquid Coexistence. Langmuir. 2019 Aug 7. doi: 10.1021/acs.langmuir.9b01696. [Epub ahead of print]
PubMed ID: 31343892Razquin C, Toledo E, Clish CB, Ruiz-Canela M, Dennis C, Corella D, Papandreou C, Ros E, Estruch R, Guasch-Ferré M, Gómez-Gracia E, Fitó M, Yu E, Lapetra J, Wang D, Romaguera D, Liang L, Alonso-Gómez A, Deik A, Bullo M, Serra-Majem L, Salas-Salvadó J, Hu FB, Martínez-González MA. Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial. Diabetes Care. 2018 Dec;41(12):2617-2624. doi: 10.2337/dc18-0840. Epub 2018 Oct 16.
PubMed ID: 30327364